Efficacy and Safety of Inhaled Triple Therapy Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Chinese Patients with Moderate-to-Very Severe COPD
单位：[1]National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, and Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China,[2]The First Hospital of China Medical University, Shenyang, Liaoning, China,[3]The First Affiliated Hospital of GuangZhou Medical University, GuangZhou, Guangdong, China,[4]Shengjing Hospital of China Medical University, Shenyang, Liaoning, China,中国医科大学附属盛京医院[5]The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China,内蒙古科技大学包头医学院[6]AstraZeneca, Shanghai, China,[7]Pearl – a member of the AstraZeneca Group, Durham, NC, United States,[8]Pearl – a member of the AstraZeneca Group, Morristown, NJ, United States.
第一作者单位：[1]National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, and Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China,
推荐引用方式(GB/T 7714)：
C. Wang,T. Yang,J. Kang,et al.Efficacy and Safety of Inhaled Triple Therapy Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Chinese Patients with Moderate-to-Very Severe COPD[J].AMERICAN JOURNAL of RESPIRATORY and CRITICAL CARE MEDICINE.2019,199:
APA：
C. Wang,T. Yang,J. Kang,R. Chen,L. Zhao...&P. Dorinsky.(2019).Efficacy and Safety of Inhaled Triple Therapy Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Chinese Patients with Moderate-to-Very Severe COPD.AMERICAN JOURNAL of RESPIRATORY and CRITICAL CARE MEDICINE,199,
MLA：
C. Wang,et al."Efficacy and Safety of Inhaled Triple Therapy Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Chinese Patients with Moderate-to-Very Severe COPD".AMERICAN JOURNAL of RESPIRATORY and CRITICAL CARE MEDICINE 199.(2019)
医学